IL1B and cancer: Cancer-induced inflammatory cytokines, particularly tumor necrosis factor-α (TNF-α) and IL-1β, downregulate endothelial thrombomodulin expression 70–90% through NF-κB-mediated transcriptional repression, while simultaneously reducing protein C receptor expression and upregulating endothelial TF expression [33,34,35].